The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Pulmonx Corporation ( NASDAQ:LUNG ) investors will be delighted, with the company turning in some strong numbers with...
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript May 1, 2024 Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.43. LUNG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. […]